Glomerulonephritis, Membranoproliferative
"Glomerulonephritis, Membranoproliferative" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chronic glomerulonephritis characterized histologically by proliferation of MESANGIAL CELLS, increase in the MESANGIAL EXTRACELLULAR MATRIX, and a thickening of the glomerular capillary walls. This may appear as a primary disorder or secondary to other diseases including infections and autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Various subtypes are classified by their abnormal ultrastructures and immune deposits. Hypocomplementemia is a characteristic feature of all types of MPGN.
| Descriptor ID |
D015432
|
| MeSH Number(s) |
C12.777.419.570.363.615 C13.351.968.419.570.363.615 C20.425
|
| Concept/Terms |
Glomerulonephritis, Membranoproliferative- Glomerulonephritis, Membranoproliferative
- Glomerulonephritides, Membranoproliferative
- Membranoproliferative Glomerulonephritides
- Glomerulonephritis, Mesangiocapillary
- Glomerulonephritides, Mesangiocapillary
- Mesangiocapillary Glomerulonephritides
- MPGN
- Membranoproliferative Glomerulonephritis
- Mesangiocapillary Glomerulonephritis
- Glomerulonephritis, Hypocomplementemic
- Glomerulonephritides, Hypocomplementemic
- Hypocomplementemic Glomerulonephritides
- Hypocomplementemic Glomerulonephritis
Membranoproliferative Glomerulonephritis, Type I- Membranoproliferative Glomerulonephritis, Type I
- Subendothelial Membranoproliferative Glomerulonephritis
- Membranoproliferative Glomerulonephritis, Subendothelial
- Mesangiocapillary Glomerulonephritis, Type I
|
Below are MeSH descriptors whose meaning is more general than "Glomerulonephritis, Membranoproliferative".
Below are MeSH descriptors whose meaning is more specific than "Glomerulonephritis, Membranoproliferative".
This graph shows the total number of publications written about "Glomerulonephritis, Membranoproliferative" by people in this website by year, and whether "Glomerulonephritis, Membranoproliferative" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glomerulonephritis, Membranoproliferative" by people in Profiles.
-
O'Shaughnessy MM, Hogan SL, Poulton CJ, Falk RJ, Singh HK, Nickeleit V, Jennette JC. Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986-2015. Clin J Am Soc Nephrol. 2017 Apr 03; 12(4):614-623.
-
Raber I, Ediriwickrema A, Higgins J, Kambham N, Pao AC. Crescentic Glomerulonephritis With Immunoglobulin G4-Related Disease. Am J Med Sci. 2017 09; 354(3):236-239.
-
Edrees F, Black RM, Leb L, Rennke H. Minimal change disease: A case report of an unusual relationship. Saudi J Kidney Dis Transpl. 2016 Jul-Aug; 27(4):816-20.
-
Costa-Reis P, Russo PA, Zhang Z, Colonna L, Maurer K, Gallucci S, Schulz SW, Kiani AN, Petri M, Sullivan KE. The Role of MicroRNAs and Human Epidermal Growth Factor Receptor 2 in Proliferative Lupus Nephritis. Arthritis Rheumatol. 2015 Sep; 67(9):2415-26.
-
Bomback AS, Smith RJ, Barile GR, Zhang Y, Heher EC, Herlitz L, Stokes MB, Markowitz GS, D'Agati VD, Canetta PA, Radhakrishnan J, Appel GB. Eculizumab for dense deposit disease and C3 glomerulonephritis. Clin J Am Soc Nephrol. 2012 May; 7(5):748-56.
-
Alexander JJ, Hack BK, Jacob A, Chang A, Haas M, Finberg RW, Quigg RJ. Abnormal immune complex processing and spontaneous glomerulonephritis in complement factor H-deficient mice with human complement receptor 1 on erythrocytes. J Immunol. 2010 Sep 15; 185(6):3759-67.
-
Kay J, McCluskey RT. Case records of the Massachusetts General Hospital. Case 31-2005. A 60-year-old man with skin lesions and renal insufficiency. N Engl J Med. 2005 Oct 13; 353(15):1605-13.